Koyfin Home > Directory > Health Care > Aduro Biotech > Cash Flow from Operations

Aduro Biotech Cash Flow from Operations Chart (ADRO)

Aduro Biotech annual/quarterly Cash Flow from Operations from 2013 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Aduro Biotech Cash Flow from Operations for the quarter ending June 06, 2020 was $-21m a 24.36% decrease of -5m year over year
  • Aduro Biotech Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-67m a 33.28% decrease of -22m year over year
  • Aduro Biotech Annual Cash Flow from Operations for 2019 was $-66m a -4.96% increase of 3m from 2018
  • Aduro Biotech Annual Cash Flow from Operations for 2018 was $-69m a -29.23% increase of 20m from 2017
  • Aduro Biotech Annual Cash Flow from Operations for 2017 was $-89m a 3.13% decrease of -3m from 2016
Other Cash Flow Metrics:
  • Aduro Biotech Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-23m a 36.84% decrease of -8m year over year
  • Aduro Biotech Total Revenue for the quarter ending December 12, 2018 was $3m a -140.28% decrease of -4m year over year
View Chart On Koyfin

Quarterly ADRO Cash Flow from Operations Data

06/2020$-21m
03/2020$-8m
12/2019$-22m
09/2019$-16m
06/2019$-16m
03/2019$-11m
12/2018$-1m
09/2018$-23m
06/2018$-24m
03/2018$-21m

Annual ADRO Cash Flow from Operations Data

2019$-66m
2018$-69m
2017$-89m
2016$-86m
2015$155m
2014$19m
2013$-14m
2012$-8m